What is Syphilis Testing Market?
Syphilis is a sexually transferred infection caused by the bacteria Treponema pallidum subspecies pallidum that can produce serious health difficulties if it is not treated. Syphilis is divided into stages primary, secondary, latent, and tertiary. There are different signs and symptoms associated with each stage. Further, the infection can affect the infants too by the transmission of the infection from the infected mother to the fetus. The rate of syphilis is high among the men who have sex with the men. The increasing number of Unprotected sex and sexual intercourse with multiple partners affected by syphilis infection is one of the major key driving factors of the growth of syphilis testing.
The market study is being classified by Type (Treponemal tests and Non-treponemal tests) and major geographies with country level break-up.
Abbott Laboratories (United States), Affymetrix (United States), Alere (United States), Becton Dickinson And Company (United States), BioMerieux(France), Beckman Coulter Life Sciences (United States), Roche Diagnostics (Switzerland), Siemens Healthcare (Germany), AccuBioTech Co., Ltd. (China) and bioLytical Laboratories (Canada) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Chembio Diagnostic Systems(United States) and DRG International (United States).
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Syphilis Testing market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Syphilis Testing market by Type, Application and Region.
On the basis of geography, the market of Syphilis Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increasing prevalence and incidence of syphilis
- Growing research and development activities
- The increased use of premarital screening for syphilis is one of the key syphilis testing market trends
- Lack of awareness regarding syphilis testing
- Increase in the prevalence of syphilis
- Discrepancies associated with the syphilis test results
In February 2020 Houston Health Department launches new campaign emphasizing the importance of prenatal care, syphilis testing for expectant mothers. The new campaign, called “My Prenatal Promise,” targets women of childbearing age (16-44), and emphasizes the importance of prenatal care and getting tested three times for syphilis, as required by Texas state law.
Key Target AudienceNew Entrants/Investors, Analysts and Strategic Business Planners, Syphilis Testing Manufacturer, Government Regulatory and Research Organizations and End-Use Industry
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase